Association of bilirubin with coronary artery calcification and cardiovascular events in the general population without known liver disease: The Heinz Nixdorf Recall study

Clinical Research in Cardiology

Volumn 103, Issue 8, 2014, Pages 647-653

  Mahabadi, Amir A ^a   Lehmann, Nils ^a   Möhlenkamp, Stefan ^a,b   Kälsch, Hagen ^a   Bauer, Marcus ^a   Schulz, Rainer ^c   Moebus, Susanne ^a   Jöckel, Karl Heinz ^a   Erbel, Raimund ^a   Heusch, Gerd ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Krankenhaus Bethanien   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Bilirubin; Cardiovascular events; Coronary artery calcification; Epidemiology; Heinz Nixdorf Recall study

Indexed keywords

BILIRUBIN;

ADULT; AGATSTON SCORE; ARTICLE; BILIRUBIN BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DISEASE ASSOCIATION; ELECTRON BEAM TOMOGRAPHY; FEMALE; FOLLOW UP; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; AGE; AGED; ATHEROSCLEROSIS; BLOOD; CALCINOSIS; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RISK FACTOR;

AGE FACTORS; AGED; ATHEROSCLEROSIS; BILIRUBIN; CALCINOSIS; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84904394519     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-014-0697-z     Document Type: Article

References (27)

1. Abraham NG, Kappas A (2008) Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60(1):79-127. doi:10.1124/pr.107.07104 (Pubitemid 351439218)
2. Li Q, Guo Y, Ou Q, Wu WJ, Chen N, Zhu X, Tan W, Yuan F, Dawn B, Luo L, Hunt GN, Bolli R (2011) Gene transfer as a strategy to achieve permanent cardioprotection II: rAAV-mediated gene therapy with heme oxygenase-1 limits infarct size 1 year later without adverse functional consequences. Basic Res Cardiol 106(6):1367-1377. doi:10.1007/s00395-011-0208-6
3. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235(4792):1043-1046 (Pubitemid 17049750)
4. Grosser N, Erdmann K, Hemmerle A, Berndt G, Hinkelmann U, Smith G, Schroder H (2004) Rosuvastatin upregulates the anti-oxidant defense protein heme oxygenase-1. Biochem Biophys Res Commun 325(3):871-876. doi:10.1016/j.bbrc. 2004.10.123 (Pubitemid 39487953)
5. Kundur AR, Bulmer AC, Singh I (2013) Unconjugated bilirubin inhibits collagen induced platelet activation. Platelets. doi:10.3109/09537104.2013. 764405
6. Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, Itabe H, Kodama T, Maruyama Y (2005) Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 25(1):155-160. doi:10.1161/01.ATV.0000148405.18071.6a (Pubitemid 40054269)
7. Jansen T, Hortmann M, Oelze M, Opitz B, Steven S, Schell R, Knorr M, Karbach S, Schuhmacher S, Wenzel P, Munzel T, Daiber A (2010) Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin. J Mol Cell Cardiol 49(2):186-195. doi:10.1016/j.yjmcc. 2010.04.011
8. Dullaart RP, Kappelle PJ, de Vries R (2012) Lower carotid intima media thickness is predicted by higher serum bilirubin in both non-diabetic and Type 2 diabetic subjects. Clin Chim Acta 414:161-165. doi:10.1016/j.cca.2012.08.029
9. Zhang ZY, Bian LQ, Jae SY, Sung JD, Choi YH (2013) Serum total bilirubin is inversely associated with brachial-ankle pulse wave velocity in men with hypertension. Heart Vessel 28(4):453-460. doi:10.1007/s00380-012-0261-6
10. Zhang ZY, Bian LQ, Kim SJ, Zhou CC, Choi YH (2012) Inverse relation of total serum bilirubin to coronary artery calcification score detected by multidetector computed tomography in males. Clin Cardiol 35(5):301-306. doi:10.1002/clc.21964
11. Kronenberg F (2010) Association of bilirubin with cardiovascular outcomes: more hype than substance? Circ Cardiovasc Genet 3(4):308-310. doi:10.1161/CIRCGENETICS.110.957399
12. Horsfall LJ, Nazareth I, Petersen I (2012) Cardiovascular events as a function of serum bilirubin levels in a large, statin-treated cohort. Circulation 126(22):2556-2564. doi:10.1161/CIRCULATIONAHA.112.114066
13. Kim KM, Kim BT, Park SB, Cho DY, Je SH, Kim KN (2012) Serum total bilirubin concentration is inversely correlated with Framingham risk score in Koreans. Arch Med Res 43(4):288-293. doi:10.1016/j.arcmed.2012.05.003
14. McArdle PF, Whitcomb BW, Tanner K, Mitchell BD, Shuldiner AR, Parsa A (2012) Association between bilirubin and cardiovascular disease risk factors: using Mendelian randomization to assess causal inference. BMC Cardiovasc Disord 12:16. doi:10.1186/1471-2261-12-16
15. Stender S, Frikke-Schmidt R, Nordestgaard BG, Grande P, Tybjaerg-Hansen A (2013) Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis. J Intern Med 273(1):59-68. doi:10.1111/j.1365-2796.2012.02576.x
16. Schmermund A, Mohlenkamp S, Stang A, Gronemeyer D, Seibel R, Hirche H, Mann K, Siffert W, Lauterbach K, Siegrist J, Jockel KH, Erbel R (2002) Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf Recall Study. Am Heart J 144(2):212-218 (Pubitemid 34879641)
17. Erbel R, Mohlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, Dragano N, Gronemeyer D, Seibel R, Kalsch H, Brocker-Preuss M, Mann K, Siegrist J, Jockel KH (2010) Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 56(17):1397-1406
18. Schmermund A, Lehmann N, Bielak LF, Yu P, Sheedy PF 2nd, Cassidy-Bushrow AE, Turner ST, Moebus S, Mohlenkamp S, Stang A, Mann K, Jockel KH, Erbel R, Peyser PA (2007) Comparison of subclinical coronary atherosclerosis and risk factors in unselected populations in Germany and US-America. Atherosclerosis 195(1):e207-e216 (Pubitemid 47566387)
19. Moebus S, Stang A, Mohlenkamp S, Dragano N, Schmermund A, Slomiany U, Hoffmann B, Bauer M, Broecker-Preuss M, Mann K, Siegrist J, Erbel R, Jockel KH (2009) Association of impaired fasting glucose and coronary artery calcification as a marker of subclinical atherosclerosis in a population-based cohort-results of the Heinz Nixdorf Recall Study. Diabetologia 52(1):81-89
20. Jockel KH, Lehmann N, Jaeger BR, Moebus S, Mohlenkamp S, Schmermund A, Dragano N, Stang A, Gronemeyer D, Seibel R, Mann K, Volbracht L, Siegrist J, Erbel R (2009) Smoking cessation and subclinical atherosclerosis - results from the Heinz Nixdorf Recall Study. Atherosclerosis 203(1):221-227
21. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15(4):827-832 (Pubitemid 20101575)
22. Sung KC, Shin J, Lim YH, Wild SH, Byrne CD (2013) Relation of conjugated bilirubin concentrations to the presence of coronary artery calcium. Am J Cardiol 112(12):1873-1879. doi:10.1016/j.amjcard.2013.08.018
23. Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Kajikawa M, Matsumoto T, Kihara Y, Chayama K, Noma K, Nakashima A, Tomiyama H, Takase B, Yamashina A, Higashi Y (2012) Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome. Circulation 126(5):598-603. doi:10.1161/CIRCULATIONAHA.112.105775
24. Ajja R, Lee DC, Sui X, Church TS, Steven NB (2011) Usefulness of serum bilirubin and cardiorespiratory fitness as predictors of mortality in men. Am J Cardiol 108(10):1438-1442. doi:10.1016/j.amjcard.2011.06.067
25. Huang SS, Huang PH, Leu HB, Wu TC, Lin SJ, Chen JW (2010) Serum bilirubin predicts long-term clinical outcomes in patients with cardiac syndrome X. Heart 96(15):1227-1232. doi:10.1136/hrt.2009.192393
26. Ekblom K, Marklund SL, Johansson L, Osterman P, Hallmans G, Weinehall L, Wiklund PG, Hultdin J (2010) Bilirubin and UGT1A1*28 are not associated with lower risk for ischemic stroke in a prospective nested case-referent setting. Cerebrovasc Dis 30(6):590-596. doi:10.1159/000319778
27. Ekblom K, Marklund SL, Jansson JH, Osterman P, Hallmans G, Weinehall L, Hultdin J (2010) Plasma bilirubin and UGT1A1*28 are not protective factors against first-time myocardial infarction in a prospective, nested case-referent setting. Circ Cardiovasc Genet 3(4):340-347. doi:10.1161/CIRCGENETICS.109. 861773